Showing results (1901-1910 of 2,353) with videos related to
Sort By:
Pageof 236
MMWR. Morbidity and Mortality Weekly Report|April 24, 2025
Measles Update - United States, January 1-April 17, 2025Adria D Mathis, Kelley Raines, Thomas D Filardo, et al.Journal of Magnetic Resonance (San Diego, Calif. : 1997)|January 16, 2013
Advances in multimodal neuroimaging: hybrid MR-PET and MR-PET-EEG at 3 T and 9.4 TN Jon Shah, Ana-Maria Oros-Peusquens, Jorge Arrubla, et al.Proceedings of the National Academy of Sciences of the United States of America|March 1, 2005
Cardiac stem cells delivered intravascularly traverse the vessel barrier, regenerate infarcted myocardium, and improve cardiac functionBuddhadeb Dawn, Adam B Stein, Konrad Urbanek, et al.Emerging Infectious Diseases|September 16, 2009
Recurrent zoonotic transmission of Nipah virus into humans, Bangladesh, 2001-2007Stephen P Luby, M Jahangir Hossain, Emily S Gurley, et al.Pathogens and Global Health|January 14, 2026
Genomic characterization of Legionella pneumophila serogroup 1 ST901 isolates responsible for recurrent travel-associated Legionnaires' disease cases and clustersMaria Luisa Ricci, Silvia Fillo, Francesco Giordani, et al.International Journal of Molecular Sciences|July 29, 2025
Automated Workflow for High-Throughput LC-MS/MS-Based Therapeutic Monitoring of Cannabidiol and 7-Hydroxy-cannabidiol in Patients with EpilepsyMichela Palmisani, Francesca Dattrino, Paola Rota, et al.Trials|June 18, 2024
Enhancing HIV pre-exposure prophylaxis outcomes among Kenyan adolescent girls and young women with a novel pharmacy-based PrEP delivery platform: protocol for a cluster-randomized controlled trialHarison K Lagat, Jillian Pintye, Elizabeth Harrington, et al.Frontiers in Neurology|June 12, 2023
Chaudhuri's Dashboard of Vitals in Parkinson's syndrome: an unmet need underpinned by real life clinical testsMubasher A Qamar, Silvia Rota, Lucia Batzu, et al.Haematologica|May 1, 1997
Idarubicin in patients with diffuse large cell lymphomas: a randomized trial comparing VACOP-B (A = doxorubicin) vs VICOP-B (I = idarubicin)M Bertini, R Freilone, B Botto, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 8, 2006
Concerted escalation of dose and dosing duration in a phase I study of the oral camptothecin gimatecan (ST1481) in patients with advanced solid tumorsC Sessa, S Cresta, T Cerny, et al.Pageof 236